Moreover, the QF-Ag cut-off of 2.48 IU/ml did not allow to reach a statistically significant difference in CMV infection-free survival at M12 between patients with a reactive and a non-reactive QF-Ag at M1. This evidence concerns the gene RENBP and cytomegalovirus infection.